HER2 Biomarker Testing in Breast and Gastrointestinal Cancers: The Role of the Pathologist

This publication provides a summary of key stakeholder insights on methodological limitations and analytical factors to consider pertaining to biomarker testing for HER2+ across cancer types, with particular emphasis on the role of the pathologist in the multidisciplinary management of cancer.

Related Videos
Sarah Sammons, MD
Laura Spring, MD
Laura Spring, MD
Aatur D. Singhi, MD, PhD
Rondell P. Graham, MBBS
Rachel E. Factor, MD, MS
Corey J. Langer, MD
John F. Lazar, MD
Rodolfo Bordoni, MD